Abstract
The rapidly evolving clinical utility of prostate-specific membrane antigen (PSMA) PET/CT as an imaging modality for prostate cancer (PCa) has brought to the forefront a multitude of non-prostatic diseases also exhibiting PSMA radioligand uptake. We report a case of a 71-year-old male with PCa who underwent PSMA PET/CT for recurrence evaluation. The scan demonstrated [68 Ga]Ga-PSMA-11 uptake in the distal ileum. Retrospective enquiry revealed that the patient was a known case of Crohn’s disease. This case highlights an uncommon finding of PSMA radioligand uptake in the distal small bowel (non-prostatic benign pathological uptake) in a patient with known Crohn’s disease, which may be misinterpreted in the evaluation of PCa.
Similar content being viewed by others
References
Jadvar H. PSMA PET in prostate cancer. J Nucl Med. 2015;56:1131–2.
Reale ML, Buttigliero C, Tucci M, Giardino R, Poti C. 68Ga-PSMA uptake in fibrous dysplasia. Clin Nucl Med. 2019;44:e396–7.
Ahuja A, Taneja S, Thorat K, Jena A. 68Ga–prostate-specific membrane antigen–avid tubercular lesions mimicking prostate cancer metastasis on simultaneous prostate-specific membrane antigen PET/MRI. Clin Nucl Med. 2017;42:e509–10.
Haemels M, Jentjens S, Cleeren F, Sciot R, Lambert J, Van Laere K, et al. All that glitters is not prostate cancer: incidental finding of PSMA-avid meningioma. Hell J Nucl Med. 2020;23:79–80.
Krishnaraju VS, Basher RK, Singh H, Singh SK, Bal A, Mittal BR. Incidental detection of type B2 thymoma on 68Ga-labeled prostate-specific membrane antigen PET/CT imaging. Clin Nucl Med. 2018;43:356–8.
Taneja S, Taneja R, Kashyap V, Jha A, Jena A. 68Ga-PSMA uptake in hepatocellular carcinoma. Clin Nucl Med. 2017;42:e69-70.
Siva S, Callahan J, Pryor D, Martin J, Lawrentschuk N, Hofman MS. Utility of 68 Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma. J Med Imaging Radiat Oncol. 2017;61:372–8.
Jochumsen MR, Bouchelouche K. Intense 68Ga-PSMA uptake in diverticulum of the sigmoid colon. Clin Nucl Med. 2018;43:110–1.
Kobe C, Maintz D, Fischer T, Drzezga A, Chang DH. Prostate-specific membrane antigen PET/CT in splenic sarcoidosis. Clin Nucl Med. 2015;40:897–8.
Klingenberg S, Jochumsen MR, Nielsen TF, Bouchelouche K. 68Ga-PSMA uptake in anal fistula on PET/CT scan. Clin Nucl Med. 2019;44:e54–6.
Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res. 1997;3:81–5.
Kinoshita Y, Kuratsukuri K, Landas S, Imaida K, Rovito PM Jr, Wang CY, et al. Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J Surg. 2006;30:628–36.
Pinto JT, Suffoletto BP, Berzin TM, Qiao CH, Lin S, Tong WP, et al. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res. 1996;2:1445–51.
Noble CL, Abbas AR, Lees CW, Cornelius J, Toy K, Modrusan Z, et al. Characterization of intestinal gene expression profiles in Crohn’s disease by genome-wide microarray analysis. Inflamm Bowel Dis. 2010;16:1717–28.
Rais R, Jiang W, Zhai H, et al. FOLH1/GCPII is elevated in IBD patients, and its inhibition ameliorates murine IBD abnormalities. JCI Insight. 2016;1:e88634.
Rais R, Jiang W, Zhai H, Wozniak KM, Stathis M, Hollinger KR, et al. Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging. Eur J Nucl Med Mol Imaging. 2017;44:2117–36.
de Galiza BF, Queiroz MA, Nunes RF, Costa LB, Zaniboni EC, Marin JFG, et al. Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings. Cancer Imaging. 2020;20:23.
Author information
Authors and Affiliations
Contributions
Material preparation and data collection were performed by Kunal Ramesh Chandekar and Sindhu Tanigassalam. The first draft of the manuscript was written by Kunal Ramesh Chandekar. Revision and editing of the manuscript was done by Anwin Joseph Kavanal, Harmandeep Singh, and Anish Bhattacharya. The referring urologist in charge was Ravimohan Suryanarayan Mavuduru who helped in the final revision. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Coflict of Interest
Kunal Ramesh Chandekar, Sindhu Tanigassalam, Anwin Joseph Kavanal, Harmandeep Singh, Anish Bhattacharya, and Ravimohan Suryanarayan Mavuduru declare no coflict of interest.
Ethics Approval and Consent to Participate
This article is to be considered for publication under the Case Report category. Hence, ethical approval is not applicable.
Consent for Publication
Informed consent of the subject was obtained as per departmental protocol.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chandekar, K.R., Tanigassalam, S., Kavanal, A.J. et al. [68 Ga]Ga-PSMA-11 Small Bowel Uptake in Crohn’s Disease: Revisiting the “Non-specificity” of PSMA Ligands. Nucl Med Mol Imaging 56, 102–104 (2022). https://doi.org/10.1007/s13139-021-00732-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-021-00732-4